𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FC1 lignanolides as potent inhibitors of HIV-1 integrase, a new target for drug development

✍ Scribed by Eich, E.; Pertz, H.; Kaloga, M.; Schulz, J.; Fesen, M.R.; Mazumder, A.; Pommier, Y.

Book ID
122697490
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
139 KB
Volume
2
Category
Article
ISSN
0928-0987

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of the next generation of HI
Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold
✍ Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati; πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 522 KB

HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which lea